PPF confirms zero levy
The Pension Protection Fund (PPF) has confirmed it will charge no levy for 2025/26, saving 5,000 UK defined benefit (DB) schemes and their sponsoring employers £45m. The change follows the Pension Schemes...
The Pension Protection Fund (PPF) has confirmed it will charge no levy for 2025/26, saving 5,000 UK defined benefit (DB) schemes and their sponsoring employers £45m. The change follows the Pension Schemes...
Cigna Healthcare’s International Health division is partnering with Headspace to expand its mental health solutions for Global Health Benefits (GHB) customers. Eligible customers and their covered dependents can get unlimited access to...
Budget anticipation is building, with rumours about changes to the 25 per cent tax-free lump sum available to most savers when accessing their pension. Royal London has already started to see a...
UK defined benefit pension schemes are still adjusting to the new funding regime a year after the introduction of the Funding Code, according to Aon. The new regime was considered the biggest...
The proportion of people seeking advice before accessing their pension for the first time has fallen again, according to the latest data from the Financial Conduct Authority. These figures show that of...
NatWest Group has instructed advisers to push the sale of NatWest Cushon, the company in which it holds an 85 per cent stake, according to media reports. Sky News has cited ‘City...
Aviva has completed bulk purchase annuity (BPA) buy-in transactions worth £113 million for the pension schemes of British department store group, Fenwick Limited. The deals are part of a series of transactions...
Bupa has appointed Chris Carroll as chief executive officer for its Global, India & UK market, effective 1 January 2026. Carroll, who currently leads Bupa Insurance in the UK, will report to...
Cash ISA subscriptions surged 26 per cent in 2023/24 from 7.86 million in 2022/23 to 9.94 million, while stocks and shares ISAs saw just a 7 per cent increase with 283,000 new...
GLP-1 weight-loss drugs could reduce UK mortality by 5.1 per cent and US mortality by up to 6.4 per cent by 2045, according to new research from Swiss Re. The reinsurer says...